Dr. Michelle Katz is a clinician and health services researcher interested in directly improving health outcomes for youth with Type 1 diabetes. Her current research efforts are aimed at decreasing later cardiovascular disease by improving the management of hypertension and dyslipidemia in Type 1 youth.
Dr. Katz works to impact diabetes care delivery on two fronts. First, she has investigated ways to increase awareness of family impacts of Type 1 diabetes and avoid diabetes complications. Second, with the support of a Career Development Award from the National Heart, Lung, and Blood Institute, she is investigating current practices for hypertension and hyperlipidemia management and is developing an intervention to improve heart healthy behaviors in youth with Type 1 diabetes at elevated cardiovascular disease risk. She has presented the results of her research at national meetings and published research in JAMA and Diabetes Care. She serves on national committees for the Pediatric Endocrine Society and American Diabetes Association.
Dr. Katz completed her undergraduate training at Duke University, medical school training at the University of Pittsburgh School of Medicine and her residency training at Yale-New Haven Hospital for Children. She was a Chief Resident in Pediatrics for the University of Connecticut Pediatric Residency Program. She completed her fellowship training in pediatric endocrinology at Massachusetts General Hospital and her Masters in Public Health at the Harvard School of Public Health. She also completed a fellowship in health services research as a part of the Harvard Pediatric Health Services Research Fellowship Program.
Dr. Katz joined the Joslin faculty in 2013 and is an Assistant Investigator in the Section on Clinical, Behavioral and Outcomes research, as well as the Associate Director for the Section of Pediatric, Adolescent and Young Adult Diabetes. She is also an Instructor in Pediatrics at Harvard Medical School.